IG-LIKE FUSION PROTEINS AND USES THEREOF
JP2024547218A5Pending Publication Date: 2025-12-23CANOPY IMMUNO-THERAPEUTICS LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- JP2024556825
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-12-13
- Filing Date
- 2022-12-13
- Publication Date
- 2025-12-23
Smart Images
Figure 00000000_0000_ABST
Abstract
A composition is provided that includes a first human receptor target of a myasthenia gravis autoantibody, or a fragment of an analog or derivative thereof, and a second human protein receptor of a myasthenia gravis autoantibody, or a fragment of an analog or derivative thereof. Pharmaceutical compositions that include the composition, nucleic acid systems that encode the polypeptides of the composition, and methods of determining treatment and suitability for treatment using the composition; and methods of manufacturing the composition are also provided.
Need to check novelty before this filing date? Find Prior Art